Aclaris Therapeutics (ACRS) Inventory (2018 - 2019)
Aclaris Therapeutics (ACRS) recorded quarterly Inventory of $189000.0 in Q3 2019, up 2.16% quarter-over-quarter from $185000.0 in Q2 2019, and down 81.9% on a YoY basis from $1.0 million in Q3 2018.
Aclaris Therapeutics (ACRS) Inventory (2018 - 2019) Analysis & Trends
Aclaris Therapeutics' Inventory history runs 2 years deep, the most recent figure standing at $189000.0 for Q3 2019.
- In Q3 2019, Inventory fell 81.9% year-over-year to $189000.0; the TTM figure through Sep 2019 stood at $189000.0 (down 81.9% YoY), while the FY2018 annual figure was $791000.0, changed N/A from the prior year.
- Inventory was $189000.0 for Q3 2019 at Aclaris Therapeutics, up from $185000.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $1.0 million in Q3 2018 to a low of $185000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aclaris Therapeutics | 580.93 Mn | 580.93 Mn | 1.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 189,000.00 |
| Jun 30, 2019 | 185,000.00 |
| Mar 31, 2019 | 856,000.00 |
| Dec 31, 2018 | 791,000.00 |
| Sep 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 1.03 Mn |